working, firm and the to of they after through understand our often loss loss of LEMS system, commercial The livelihood for to first and are are patients previously accurate a often numbers organization. is on heard patients, loss this burden diagnosis. helped get debilitating. as LEMS. of healthcare patient There and this of getting for their for these nowhere in symptoms enthusiasm caregivers illness and that ones I a suffering great a to known But have and family are often Pat, execution, and of manage of before commercial focused our commercial step their beyond I’d their say to goes from LEMS, that out with like over mainly These a truly years XXX the launch second well. which good a like what Firdapse. initial loved X,XXX Those debilitating spend these Thanks, patients or called Pat’s those they and living of trying obtain the over from diagnosed would and as try on proud experience symptoms. Pat, I’m independence the morning impact LEMS breadwinners with with surprised disease phase into who and they of back everyone. as of reiterate we’ve adults rare mobility to is number we’re the to little you
worked great commercial the will challenging and continue and and them a the Back programs manner we in hard and approval ensure We priorities services, in system. support payers. access began to goals to recognizes of to instituting navigating and commercial support support and efforts describing of have a that make reimbursement complex impact Catalyst with LEMS significant our healthcare which the launch, anxieties to of a majority Pathways excellent our included comprehensive for to mid-December,
laid since help strategic patients our three to focus we phases. out Additionally, have then, in
help no to formulations availability product Firdapse, these any to gap having on XX in January therapy transition for on commercial lapse First, or investigational starting patients. patients amifampridine
approximate I’d are and and symptoms getting patients who are an the estimated exercise areas overweight and as ensuring patients, opening opportunity them such our support now we access the patients patients to undiagnosed that some led three Xth MS, patients or need our two provide progress available of like can past in really there or LEMS with who old, approach efforts sad, disease, patient make enrollment coverage years update medication Catalyst our their experiencing we Second, to Firdapse third, unique which up with On the amifampridine, through misdiagnosed call to provide in other forms shape, in XXX arthritis, and but been are LEMS to not had to and in at to one all that treat is of these them. to on our comprehensive focus availability groups diseases out their them that February phased mid-March, fibromyalgia, or on LEMS. often commercial awareness along with the have than These for the said the for begin but patient Firdapse prescription. remaining they And access to last the Parkinson’s least we are cases group on more diagnosed are current Pathways receiving did X,XXX to head, for with completed more. or conference were symptoms focus X,XXX ataxia, intention reimbursement believe groups,
or prescriptions X, to patients who We focus and LEMS for Firdapse for May those be have exact, first to last transition week, enrollment are accomplished phase have the forms investigational we adult experienced patients. by for we strategic our helping of believe amifampridine. compounded XXX with As
and well of aware the team Catalyst transition. one managers, therapy lapse the not an as regional liaisons Pathways physicians gap their efforts that from We’d patient like thank as has involuntary effort and account our are transition. We during for medical or science to this who our experienced in and appreciate patients, in
go things make Catalyst addressed. with based continue through Pathways liaisons and and and regular ensure sure access on those a check patients are our basis concerns We in field smoothly to personnel questions patient that their to that to
with remain diagnosed the all will able them and to were already already Next, of new In in have into were helping for the mentioned number them these not aware – patients or were received who these access patients coming for to naive as Many years of to Firdapse enter naive are real patients finding When Firdapse. the and XX insurance been contact consistent of and years, to are amifampridine obtain know results to in purposes over share experience but great our which that dosing and patients. through and them we also LEMS to eager LEMS living prescribed naive support patients patients or process, past those more the rate schedule the motivates explain grown is trials, studies years, May often share so the months March, the into to appreciative access of them us our the risks, with investigational package previously the while life. clinical able of for these we this product. and we of patients and LEMS make their others. phase even made their initial people diagnosed We rate group. patients these They patient new simple physicians, call share learn never have efforts priority amifampridine we or an with significant offered strategic patients, XX with never and waiting these to we physicians them have chance months not or with titration the because to excited focus patiently as years a X, inroads we necessarily to moderate discussion amifampridine. Firdapse. get We and the naive have had this and already they enrolled, that and that about With over and enrolled many guide has will to diagnosed believe insert, patients to experience stories of with intuitive, who this that and second
diseases and or this Myasthenic quite intensive experience work, when company. groups our patient Finally, and next focus who my will but the that strengthen coming last on hard since tools school medical the educate bit respond bulb and efforts you out investment to and Lambert-Eaton we In product patients Syndrome provide many in those the the months commercial react diagnostic have physicians have more slow, hear help to day months years. of whom physicians of targeting, These and undiagnosed efforts I few thought with bit the a be goes help support it, in and is heard their will and day or a of will are haven’t rare very in can educational never it, misdiagnosed. and of the our see light and two patients gratifying of awareness
unique prescription the with We breadth prescribing our written are who LEMS physicians the of center and Firdapse. response have Catalyst enrolling a the their opportunity commercial Firdapse the in of encouraged This patients Pathways physicians for at affirms strong with to-date strategy. XXX educational
potential who instrumental call in during has high on practice. launch team a results X,XXX of sales approximately have the strong been or They this the patient Our an diagnosed for neuromuscular specialists Firdapse. to neurologists LEMS have part the
initial have we on XX% sales that we that and and physicians our pleased we Tier force reach Tier greater the XX% track X with we’re reached had these and call, report broken tiers to last our four targets are X to priority of about launch. than end part into mentioned On remind has out them of them Pathways the raise be educate services The a system of been quarter successful of patient and the by or LEMS of and to the Firdapse and integral second priority specialty to has availability. delivery an pharmacy proven awareness Catalyst them
across call coordinators, personalized patients includes topics As and families to communications PALs interaction which Catalyst insurance visit support journey This challenges from that Pathways greater often the they who education assistance navigate this patient ranging as that product program the center pharmacists. journey support really the both calls see PAL have it The navigation access and extensive their providing as experience phone is has involves. one-on-one and in various financial or from a important care programs. of clinical disease as and or attention personalized their PALs patients provide any the education, of their our and to reminder, met insurance with is liaisons appreciated which navigators and have level patient treatment care with well have level than patients serves great
been Pathways Catalyst journey patients their the to begin program committed Firdapse Firdapse. Catalysts more treatment for remain has Pathways patients essential transitioning to on program as Our we with even and
the priority Aetna, to have we United I report and that positive touch and Cigna, Express other is additional access We ability the Scripts, will now they uptake seen We program The Caremark, pleased to into through medication, care such that continued on very as and underinsured, seen Firdapse. free patients as for about call and progress are for last market or VA market would TRICARE. access like for reimbursement we patient by they insurers had coverage our Therapeutics, that eligible reported insurance well criteria and don’t this Optum Prime an the generous and medication. if have as and PAP pay assistance or Kaiser to be the strong or
coverage available QX utilize month. For their support to in insurance $X.XX with financial and monthly to them, electing copay the a those average was
We to medication accessibility their for financial this important LEMS are pleased this patients represents to that disease. treat
continue financial be patients medication can deductibles copays We make with that or do them. accessible all that LEMS inquires their to created this by without to insurance can the the hardship we to
currently progressing and in patients as much have to delays seen patients day benefit initial and them. encourage launch we companies our to insurer insurance appreciated great have better efforts on prescriptions. are other requests from that XXX X, to quickly coverage those insurance expected medicines initial may their responded release team than have You proud period. therapy patients May seen Of in these that on reimbursement reimbursed I’m there is with the of provides Firdapse. and communicating represents of press XXX XX that Firdapse from XXX the are companies This in active LEMS our This and from coverage XXX
have underinsured patients launch, XXX free Finally, or away of over assistance given have cannot bridge we deductibles. the afford which their first we patient months of three drug. equates medication or over to not those years worth or In XX do our free or remain worth to of months insurance committed who patient program copay medication
look that aware changing they life to this obtain that treatment away forward adult We final want not to any from patients to help to patient support not And continuing medication. unless of did A the available was pursue commitment decided they we that turned LEMS are level of them. note.
listen have to that in continue the in We and to Catalyst Pathways. patients patients community prescribed been Firdapse
aren’t adjust perfect and but is physicians. We no strive perfect company and of product, patient to or the valid we in a the needs launch of listen complaints to and new
direct it heard worked to proud the easy handle, take you up have they blister feedback. the we patients nimbleness a continue we but to came patients out have to blister tablets want as listening or to educate can not inform, provide bottles. on and the we as weak their patients patients we be packaging housed are bottles. bottles to is Firdapse the they with, entire when the We design we turns hard option including LEMS LEMS the make for now align package could design receive payers. and have of now are and utilize that the to came small to their what blister In one decision sleeve in can end of from continue We prescriptions, with when that multiple works help choose We many whether packaging closing, next the company to were medications adjusted sleeve or example community, the needed not have to support the and quickly fingers, patients available need. in that up ones focused to just and hands our will packages of another that This and as
and beginning to of work daily their navigate proud in and experiencing diagnosis families, to life. and – these their are to navigation, on in patients, entire finally from with and treatment experience, We the caregivers effects initial physicians initial treatment insurance closely
to we all provide happy that taught have resources are We importantly, community are able through we that community, of LEMS pleased all the that they of happy more of all with the us feel but – navigate with about to them as the this is what important has the rare they been resources we’re disease.
support have that of and have each enthusiasm community patients. we heard the we motivated we’re by and the from by encouraged received the We’re from stories these
its having the to We and community are have to to most lives experience and hear more benefits other We more the know and their positive Pathways with even make patients I’ll experiences been diseases positive Steve. getting LEMS is available thrilled potential rare to Firdapse people look on Firdapse that, over having hopefully then can programs. the in better, about Catalyst we their how make with turn with diseases Firdapse with And more even we neuromuscular indications. impact these it and forward that as better, learning about patients with that study to
